News
SINT
1.560
+1.30%
0.020
Weekly Report: what happened at SINT last week (1102-1106)?
Weekly Report · 1d ago
Anthony Vendetti Maintains SINTX Technologies’ $6 Price Target on Strong Q3 Performance and Growth Prospects
TipRanks · 3d ago
SINTX Technologies, Inc. Reports Third Quarter 2026 Revenue of approximately $2.2 million
NASDAQ · 4d ago
Sintx Technologies reports Q3 EPS (24c), consensus (31c)
TipRanks · 5d ago
SINTX Technologies Reports Strong Third-Quarter Revenue Growth and Narrower Losses
TipRanks · 5d ago
Weekly Report: what happened at SINT last week (1026-1030)?
Weekly Report · 11/02 10:19
Weekly Report: what happened at SINT last week (1019-1023)?
Weekly Report · 10/26 10:19
Weekly Report: what happened at SINT last week (1012-1016)?
Weekly Report · 10/19 10:19
Transcript: SINTX Technologies Q2 2026 Earnings Conference Call
Benzinga · 10/14 08:54
Weekly Report: what happened at SINT last week (1005-1009)?
Weekly Report · 10/12 10:24
Sintx Technologies Completes Class B Warrant Exercises
TipRanks · 10/09 21:31
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock
NASDAQ · 10/08 15:00
Weekly Report: what happened at SINT last week (0928-1002)?
Weekly Report · 10/05 10:24
Sintx Technologies: Strong Q3 Beat, Scalable Growth and Upcoming Product Launches Support Unchanged $6 Price Target and Buy Rating
TipRanks · 10/03 11:55
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/02 21:05
SINTX reports preliminary $2.2M Q3 revenue, exceeds guidance and triggers call right on Class B warrants
Seeking Alpha · 10/01 14:03
Sintx Technologies Reports Surging Preliminary Third-Quarter Revenue
TipRanks · 10/01 13:25
Sintx Technologies reports preliminary Q3 revenue $2.2M
TipRanks · 10/01 13:20
SINTX Reports Preliminary Q3 Revenue of $2.2M, Exceeding High End Of Company’s Previously Announced Guidance Of $0.9M-$1.1M
Benzinga · 10/01 13:10
SiNtx Technologies Price Target Raised to $12.50/Share From $12.00 by Ascendiant Capital
Dow Jones · 10/01 09:33
More
Webull provides a variety of real-time SINT stock news. You can receive the latest news about Sintx Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About SINT
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.